Dual Imaging Gold Nanoplatforms for Targeted Radiotheranostics

Archive ouverte

Silva, Francisco | Paulo, António | Pallier, Agnès | Même, S. | Tóth, Éva | Gano, Lurdes | Marques, Fernanda | Geraldes, Carlos F.G.C. | Castro, M. Margarida C.A. | Cardoso, Ana | Jurado, Amália | López-Larrubia, Pilar | Lacerda, Sara | Cabral Campello, Maria Paula

Edité par CCSD ; MDPI -

International audience. Gold nanoparticles (AuNPs) are interesting for the design of new cancer theranostic tools, mainly due to their biocompatibility, easy molecular vectorization, and good biological half-life. Herein, we report a gold nanoparticle platform as a bimodal imaging probe, capable of coordinating Gd 3+ for Magnetic Resonance Imaging (MRI) and 67 Ga 3+ for Single Photon Emission Computed Tomography (SPECT) imaging. Our AuNPs carry a bombesin analogue with affinity towards the gastrin releasing peptide receptor (GRPr), overexpressed in a variety of human cancer cells, namely PC3 prostate cancer cells. The potential of these multimodal imaging nanoconstructs was thoroughly investigated by the assessment of their magnetic properties, in vitro cellular uptake, biodistribution, and radiosensitisation assays. The relaxometric properties predict a potential T 1-and T 2-MRI application. The promising in vitro cellular uptake of 67 Ga/Gd-based bombesin containing particles was confirmed through biodistribution studies in tumor bearing mice, indicating their integrity and ability to target the GRPr. Radiosensitization studies revealed the therapeutic potential of the nanoparticles. Moreover, the DOTA chelating unit moiety versatility gives a high theranostic potential through the coordination of other therapeutically interesting radiometals. Altogether, our nanoparticles are interesting nanomaterial for theranostic application and as bimodal T 1-and T 2-MRI / SPECT imaging probes.

Suggestions

Du même auteur

"Dual Imaging Gold Nanoplatforms for Targeted Radiotheranostics"

Archive ouverte | Lacerda, S. | CCSD

International audience

Radiopharmaceuticals for targeted radiotherapy.

Archive ouverte | Marques, Fernanda | CCSD

International audience. This work intends to find specific radiopharmaceuticals for cancer therapy based on beta (153Sm and 166Ho) or Auger (99Tc(m)) emitter radionuclides, using cyclic and acyclic polyamines as bif...

Biological evaluation of 153Sm and 166Ho complexes with tetraazamacrocycles containing methylcarboxylate and/or methylphosphonate pendant arms

Archive ouverte | Marques, Fernanda | CCSD

International audience. 153Sm and 166Ho complexes with two series of tetraazamacrocyclic ligands containing methylcarboxylate and/or methylphosphonate pendant arms were synthesized and their charge, lipophilicity, p...

Chargement des enrichissements...